Search results
Over 250 life sciences respondents from North America, Latin America, Europe and Asia Pacific were consulted on their thoughts relating to the changing market conditions, challenges and opportunities affecting life sciences business models, growth patterns, funding and shifting operational dynamics.
1 lut 2015 · In this article we examine the evolution of biotechnology during the past three decades and the profound impact that it has had on health care through four interrelated and interdependent tracks:...
26 lip 2024 · Biotech companies strengthen the nation's status as a life sciences leader, whether they're discovering new treatments or harnessing the power of genetics.
Life Sciences companies are innovators at the core of what they do in this world. They change the course of disease, and that’s miraculous. The question is ‘Now what? Where can we take innovation next?’” – Richard Schwartz, Head of Life Sciences Experience, Medallia
At the core, life sciences tools companies provide essential goods and services to contract research organizations (CROs) contract development and manufacturing organizations (CDMOs), diagnostics firms, and biopharmaceutical companies (see Figure 1). These entities collaborate to research, develop, manufacture, and market novel diagnostics and ...
25 kwi 2024 · The life science industry is at the forefront of addressing some of the most pressing challenges of our time, from healthcare to environmental sustainability. It is a rapidly evolving field, with continuous technological advancements, research methodologies, and global regulatory landscapes shaping its future.
31 maj 2024 · In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, changes in US regulations, and the acceleration of Generative AI (GenAI) adoption to expedite drug discovery, cost reduction and revenue uplift.
